Targeting the EGFR signaling pathway in cancer therapy P Seshacharyulu, MP Ponnusamy, D Haridas, M Jain, AK Ganti, SK Batra Expert opinion on therapeutic targets 16 (1), 15-31, 2012 | 1008 | 2012 |
Phosphatase: PP2A structural importance, regulation and its aberrant expression in cancer P Seshacharyulu, P Pandey, K Datta, SK Batra Cancer letters 335 (1), 9-18, 2013 | 536 | 2013 |
Easi-CRISPR: a robust method for one-step generation of mice carrying conditional and insertion alleles using long ssDNA donors and CRISPR ribonucleoproteins RM Quadros, H Miura, DW Harms, H Akatsuka, T Sato, T Aida, R Redder, ... Genome biology 18, 1-15, 2017 | 459 | 2017 |
MUC16: molecular analysis and its functional implications in benign and malignant conditions D Haridas, MP Ponnusamy, S Chugh, I Lakshmanan, P Seshacharyulu, ... The FASEB Journal 28 (10), 4183-4199, 2014 | 158 | 2014 |
Pancreatic tumor microenvironment factor promotes cancer stemness via SPP1–CD44 axis P Nallasamy, RK Nimmakayala, S Karmakar, F Leon, P Seshacharyulu, ... Gastroenterology 161 (6), 1998-2013. e7, 2021 | 133 | 2021 |
Clinical implications of miRNAs in the pathogenesis, diagnosis and therapy of pancreatic cancer S Rachagani, MA Macha, N Heimann, P Seshacharyulu, D Haridas, ... Advanced drug delivery reviews 81, 16-33, 2015 | 105 | 2015 |
Biological determinants of radioresistance and their remediation in pancreatic cancer P Seshacharyulu, MJ Baine, JJ Souchek, M Menning, S Kaur, Y Yan, ... Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1868 (1), 69-92, 2017 | 100 | 2017 |
Focal adhesion kinase a potential therapeutic target for pancreatic cancer and malignant pleural mesothelioma R Kanteti, T Mirzapoiazova, JJ Riehm, I Dhanasingh, B Mambetsariev, ... Cancer biology & therapy 19 (4), 316-327, 2018 | 96 | 2018 |
MicroRNAs (miRNAs) as biomarker (s) for prognosis and diagnosis of gastrointestinal (GI) cancers M A Macha, P Seshacharyulu, S Ram Krishn, P Pai, S Rachagani, M Jain, ... Current pharmaceutical design 20 (33), 5287-5297, 2014 | 94 | 2014 |
Cigarette smoke induces stem cell features of pancreatic cancer cells via PAF1 RK Nimmakayala, P Seshacharyulu, I Lakshmanan, S Rachagani, ... Gastroenterology 155 (3), 892-908. e6, 2018 | 86 | 2018 |
MUC16 regulates TSPYL5 for lung cancer cell growth and chemoresistance by suppressing p53 I Lakshmanan, S Salfity, P Seshacharyulu, S Rachagani, A Thomas, ... Clinical Cancer Research 23 (14), 3906-3917, 2017 | 84 | 2017 |
Mucin (Muc) expression during pancreatic cancer progression in spontaneous mouse model: potential implications for diagnosis and therapy S Rachagani, MP Torres, S Kumar, D Haridas, M Baine, MA Macha, ... Journal of hematology & oncology 5, 1-12, 2012 | 83 | 2012 |
MUC16 contributes to the metastasis of pancreatic ductal adenocarcinoma through focal adhesion mediated signaling mechanism S Muniyan, D Haridas, S Chugh, S Rachagani, I Lakshmanan, S Gupta, ... Genes & cancer 7 (3-4), 110, 2016 | 80 | 2016 |
MUC5AC interactions with integrin β4 enhances the migration of lung cancer cells through FAK signaling I Lakshmanan, S Rachagani, R Hauke, SR Krishn, S Paknikar, ... Oncogene 35 (31), 4112-4121, 2016 | 77 | 2016 |
PR55α subunit of protein phosphatase 2A supports the tumorigenic and metastatic potential of pancreatic cancer cells by sustaining hyperactive oncogenic signaling AL Hein, P Seshacharyulu, S Rachagani, YM Sheinin, MM Ouellette, ... Cancer research 76 (8), 2243-2253, 2016 | 70 | 2016 |
Emerging role of mucins in epithelial to mesenchymal transition M P Ponnusamy, P Seshacharyulu, I Lakshmanan, A P Vaz, S Chugh, ... Current cancer drug targets 13 (9), 945-956, 2013 | 68 | 2013 |
Targeting EGF-receptor (s)-STAT1 axis attenuates tumor growth and metastasis through downregulation of MUC4 mucin in human pancreatic cancer P Seshacharyulu, MP Ponnusamy, S Rachagani, I Lakshmanan, ... Oncotarget 6 (7), 5164, 2015 | 58 | 2015 |
A concise review on the current understanding of pancreatic cancer stem cells AP Vaz, MP Ponnusamy, P Seshacharyulu, SK Batra Journal of cancer stem cell research 2, 2014 | 57 | 2014 |
MUC4 stabilizes HER2 expression and maintains the cancer stem cell population in ovarian cancer cells MP Ponnusamy, P Seshacharyulu, AP Vaz, P Dey, SK Batra Journal of Ovarian Research 4, 1-10, 2011 | 56 | 2011 |
FDPS cooperates with PTEN loss to promote prostate cancer progression through modulation of small GTPases/AKT axis P Seshacharyulu, S Rachagani, S Muniyan, JA Siddiqui, E Cruz, ... Oncogene 38 (26), 5265-5280, 2019 | 55 | 2019 |